These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5060457)

  • 1. Effect of cortisone therapy on the diurnal pattern of growth hormone secretion in congenital adrenal hyperplasia.
    Vazquez AM; Schutt-Aine JC; Kenny FM
    J Pediatr; 1972 Mar; 80(3):433-40. PubMed ID: 5060457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Corticosteroid treatment regimes and growth hormone secretion in congenital adrenogenital syndrome].
    Balsamo A; Cicognani A; Guacci P; Cassio A; Cacciari E
    Pediatr Med Chir; 1993; 15(6):585-7. PubMed ID: 8197019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single dose dexamethasone in treatment of congenital adrenocortical hyperplasia.
    Hayek A; Crawford JD; Bode HH
    Metabolism; 1971 Sep; 20(9):897-901. PubMed ID: 4327743
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Postural hypotension as evidence of inadequate glucocorticoid treatment in congenital adrenal hyperplasia.
    Kirkland JL; Kirkland RT; Clayton GW
    J Pediatr; 1974 Dec; 85(6):870. PubMed ID: 4420028
    [No Abstract]   [Full Text] [Related]  

  • 5. Congenital adrenal hyperplasia.
    Newns GH
    Arch Dis Child; 1974 Jan; 49(1):1-3. PubMed ID: 4361888
    [No Abstract]   [Full Text] [Related]  

  • 6. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear growth and growth hormonal responsiveness in treated congenital adrenal hyperplasia.
    Sperling MA; Kenny FM; Schutt-Aine JC; Drash AL
    Am J Dis Child; 1971 Nov; 122(5):408-13. PubMed ID: 5129529
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronopharmacology of hydrocortisone and 9 alpha-fluorhydrocortisone in the treatment for congenital adrenal hyperplasia.
    Moeller H
    Eur J Pediatr; 1985 Nov; 144(4):370-3. PubMed ID: 4076253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone secretion in congenital adrenal hyperplasia.
    Finkelstein JW; Boyar RM; Roffwarg HP; Kream J; Fukushima DK; Gallagher TF; Hellman L
    J Clin Endocrinol Metab; 1973 Jan; 36(1):121-4. PubMed ID: 4681876
    [No Abstract]   [Full Text] [Related]  

  • 10. Circadian variation in plasma 17-hydroxyprogesterone in patients with congenital adrenal hyperplasia.
    Atherden SM; Barnes ND; Grant DB
    Arch Dis Child; 1972 Aug; 47(254):602-4. PubMed ID: 5046776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of congenital adrenal hyperplasia with cortisone: comparison of intramuscular and oral dosage.
    WILKINS L; GARDNER LI; CRIGLER JF; MIGEON CJ
    Trans Assoc Am Physicians; 1951; 64():160-7. PubMed ID: 14884247
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
    Charmandari E; Pincus SM; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia.
    Charmandari E; Calis KA; Keil MF; Mohassel MR; Remaley A; Merke DP
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3197-200. PubMed ID: 12107224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable efficacy of glucocorticoids in congenital adrenal hyperplasia.
    Hansen JW; Loriaux DL
    Pediatrics; 1976 Jun; 57(6):942-7. PubMed ID: 934750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear growth rate, bone maturation and growth hormone secretion in prepubertal children with congenital adrenal hyperplasia.
    Rappaport R; Bouthreuil E; Marti-Henneberg C; Basmaciogullari A
    Acta Paediatr Scand; 1973 Sep; 62(5):513-9. PubMed ID: 4754146
    [No Abstract]   [Full Text] [Related]  

  • 16. Temporal and individual variations in the dose of glucocorticoid used for the treatment of salt-losing congenital virilizing adrenal hyperplasia due to 21-hydroxylase deficiency.
    Sandrini R; Jospe N; Migeon CJ
    Acta Paediatr Suppl; 1993 Mar; 388():56-60; discussion 61. PubMed ID: 8329832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control in congenital adrenal hyperplasia monitored by frequent saliva 17OH-progesterone measurements.
    Hughes IA; Read GF
    Horm Res; 1984; 19(2):77-85. PubMed ID: 6538545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Control of child development as the basis of monitoring the treatment of congenital adrenal hyperplasia].
    Rybakowa M; Sołtysik-Wilk E
    Folia Med Cracov; 1986; 27(1-2):3-8. PubMed ID: 3732956
    [No Abstract]   [Full Text] [Related]  

  • 19. [Growth and somatotropin secretion in differently treated patients with congenital adrenogenital syndrome].
    Cicognani A; Tassoni P; Lazzari R; Pirazzoli P; Cacciari E
    Minerva Pediatr; 1971 Oct; 23(41):1691-9. PubMed ID: 5133183
    [No Abstract]   [Full Text] [Related]  

  • 20. Timing and type of glucocorticoid replacement in adult congenital adrenal hyperplasia.
    Ross RJ; Rostami-Hodjegan A
    Horm Res; 2005; 64 Suppl 2():67-70. PubMed ID: 16286775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.